|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hodgkin's lym phoma:ESMO clinical practice guidelines for diagno sis, treatment and follow-up显示文摘 | Eichenauer DA Engert A Dreyling M | 2011 | Ann Oncol2011，22，： | 1 |
| 2 | Two cy-cles of doxorubicin,bleomycin,vinblastine,and dacarba-zine plus extended-field radiotherapy is superior to radio-therapy alone in early favorable Hodgkin's lymphoma:fi-nal results of the GHSG HD7trial显示文摘 | ENGERT A FRANKLIN J EICH H T | 2007 | J Clin Oncol2007，25，： | 1 |
| 3 | Reduced treatment intensity in patients with early stage Hodgkin lymphoma 显示文摘 | Engert A Plutschow A Eich HT | 2010 | N Engl J Med2010，363，7： | 1 |
| 4 | Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease显示文摘 | Clee S M Zwinderman A H Engert J C | 2001 | Circulation2001，103，9： | 1 |
| 5 | Reduced treatment intensitiy in patients with early stage Hodgkin lymphoma显示文摘 | Engert A Plu tschow A Eich HT | 2010 | N Engl J Med2010，363，7： | 1 |
| 6 | Fludarabine in chronic lymphocytic leukaemia显示文摘 | Eher T Hallek M Engert A | 2006 | Expert Opin Pharmacother2006，7，12： | 1 |
| 7 | Phase Ⅰ/Ⅱ study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma显示文摘 | Ansell S M Horwitz S M Engert A | 2007 | J Clin Oncol2007，25，19： | 1 |
| 8 | An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab 显示文摘 | Boye J Elter T Engert A | 2003 | Ann Oncol2003，14，4： | 1 |
| 9 | Immunotherapy of Hodgkins lymphoma显示文摘 | BORCHMANN P SCHNELL R ENGERT A | 2005 | Haemstol Suppl2005，5，66： | 1 |
| 10 | Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 study显示文摘 | Engert A Diehl V Franklin J | 2009 | J Clin Oncol2009，27，： | 1 |
| 11 | Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization 显示文摘 | Reiser M Josting A Draube A Mapara MY Scheid C Chemnitz J Tesch H Wolf J Diehl V Sohngen D Engert A | 1999 | Bone Marrow Transplant1999，23，12： | 1 |
| 12 | Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma 显示文摘 | Reiser M Josting A Dias Wickramanayake P Draube A Scheid C Tesch H Wolf J Diehl V Engert A | 1999 | Leuk Lymphoma1999，33，34： | 1 |
| 13 | Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy Hodgkin' s lymphoma: final results of the GHSG HD7 trial 显示文摘 | Engert A Franklin J Eich HT | 2007 | J Clin Oncol2007，25，23： | 1 |
| 14 | Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 study显示文摘 | Engert A Diehl V Franklin J | 2009 | J Clin Oncol2009，27，27： | 1 |
| 15 | A real-time PCR assay for the quantification of residual malignant cells in B cell chronic lymphatic leukemia显示文摘 | PFITZNER T ENGERT A WITTOR H | 2000 | Leukemia2000，14，： | 1 |
| 16 | Reduced treatment intensity in patients with early stage Hodgkin lymphoma 显示文摘 | Engert A Plutschow A Eich HT | 2010 | N Engl J Med2010，363，7： | 1 |
| 17 | Modern concepts in the biology,diagnosis,differential diagnosis and treatment of primary central nervous system lymphoma显示文摘 | Deckert M Engert A Bruck W | 2011 | Leukemia2011，25，12： | 1 |
| 18 | Modern concepts in the biology, diagnosis, diffelntial diagnosis and treatment of primary central nervous system lymphoma 显示文摘 | Deckert M Engert A Briick W | 2011 | l eukemia2011，25，12： | 1 |
| 19 | Monoclonal anti-CD20 antibody rituximab for treatment of CD20 positive Hodgkin's lymphoma: the German experience (abstract) 显示文摘 | Rehwald U Engert A Diehl V | 2000 | Blood2000，96，： | 1 |
| 20 | Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma:10 years of follow-up of the GHSG HD9 Study显示文摘 | Engert A Diehl V Franklin J | 2009 | J Clin Oncol2009，27，27： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员